Clefamide
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101648This classification denotes an antiprotozoal agent with the molecular formula C17H16Cl2N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4AZ2V8K4EK, chemically known as 2,2-dichloro-n-(2-hydroxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide but generally known as clefamide, which bears US NIH Compound Identifier 71819. European Medicines Agency schedules Clefamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06647MIG. The term CLEFAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules clefamide in its Anatomical Therapeutic Chemical (ATC) Classification. CLEFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clefamide under HS 29242995 and SITC 51479. As of Q4 2014, CLEFAMIDE remains the US FDA Preferred Term for this commodity. Clefamide bears US NLM identifiers UMLS ID C0610174 and NCI Concept Code C78099. SMILES: CLC(CL)C(=O)N(CC1CCC(OC2CCC([N](=O)O)CC2)CC1)CCO.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.